Skip to content
Fencer Vulns
medium 6.5

CVE-2017-12714 json

Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" c…

published 2018-04-25 8 y ago modified 2026-06-17 4 mo ago also EUVD-2017-4253

cvss
6.5
version 3.0, NVD
cisa kev
Not listed
not in CISA's catalog
epss
0.6%
EPSS 0.6% chance of exploitation in 30 days, percentile 50%
public exploits
0
none known

Summary

Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" commands that can be received, which may allow a nearby attacker to repeatedly send commands to reduce pacemaker battery life. CVSS v3 base score: 5.3, CVSS vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H. Abbott has developed a firmware update to help mitigate the identified vulnerabilities.

Patch / fix

  • abbott accent_firmware f0b.0e.7e
  • abbott anthem_firmware f0b.0e.7e
  • abbott accent_mri_firmware f10.08.6c
  • abbott accent_st_firmware f10.08.6c
  • abbott assurity_firmware f14.07.80
  • abbott allure_firmware f14.07.80
  • abbott assurity_mri_firmware f17.01.49

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSMA-18-107-01 updated cvss 5.3

Abbott Laboratories Defibrillator

  • Abbott Laboratories Current distributed < april 1, 2018 Abbott Laboratories Ellipse distributed < april 1, 2018 Abbott Laboratories Fortify distributed < april 1, 2018 Abbott Laboratories Fortify Assura distributed < april 1, 2018 Abbott Laboratories Promote distributed < april 1, 2018 Abbott Laboratories Promote Quadra distributed < april 1, 2018
    +5 more products
    Abbott Laboratories Quadra Assura distributed < april 1, 2018 Abbott Laboratories Quadra Assura MP distributed < april 1, 2018 Abbott Laboratories Unify distributed < april 1, 2018 Abbott Laboratories Unify Assura distributed < april 1, 2018 Abbott Laboratories Unify Quadra distributed < april 1, 2018
    affected: vendor fix sjm.com

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

cisa ICSMA-17-241-01 updated cvss 5.3

ICSMA-17-241-01_Abbott Laboratories ' Accent/Anthem, Accent MRI, Assurity/Allure, and Assurity MRI Pacemaker Vulnerabilities

  • Abbott Laboratories Accent MRI < august 28 Abbott Laboratories Accent/Anthem < august 28 Abbott Laboratories Assurity MRI < august 28 Abbott Laboratories Assurity/Allure < august 28
    affected: mitigation

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

Exploit prediction

0.63% chance of exploitation in the next 30 days, higher than 50% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by version score vector
NVD 3.0 6.5 CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
NVD 2.0 6.1 AV:A/AC:L/Au:N/C:N/I:N/A:C

Affected products

  • Abbott Laboratories Accent/Anthem, Accent MRI, Assurity/Allure, and Assurity MRI.

Classification

Weakness
  • CWE-920 Improper Restriction of Power Consumption

References

Sources

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.